BioCryst Pharmaceuticals
BCRX
#4675
Rank
โ‚น210.28 B
Marketcap
โ‚น827.37
Share price
2.35%
Change (1 day)
-7.76%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚น210.28 Billion

As of June 2026 BioCryst Pharmaceuticals has a market cap of โ‚น210.28 Billion. This makes BioCryst Pharmaceuticals the world's 4675th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น210.28 B45.68%
2025โ‚น144.34 B5.36%
2024โ‚น137.00 B34.14%
2023โ‚น102.13 B-42.33%
2022โ‚น177.09 B-4.53%
2021โ‚น185.49 B92.82%
2020โ‚น96.20 B153.78%
2019โ‚น37.90 B-38.96%
2018โ‚น62.10 B101.31%
2017โ‚น30.85 B-2.76%
2016โ‚น31.72 B-36.93%
2015โ‚น50.30 B-9.28%
2014โ‚น55.45 B99.87%
2013โ‚น27.74 B601.19%
2012โ‚น3.95 B-33.02%
2011โ‚น5.90 B-43.28%
2010โ‚น10.41 B-20.86%
2009โ‚น13.16 B422.41%
2008โ‚น2.51 B-72.64%
2007โ‚น9.20 B-38.51%
2006โ‚น14.97 B-31.05%
2005โ‚น21.71 B298.75%
2004โ‚น5.44 B-2.28%
2003โ‚น5.57 B585.68%
2002โ‚น0.81 B-75.84%
2001โ‚น3.36 B-37.96%
2000โ‚น5.42 B-75.51%
1999โ‚น22.14 B397.23%
1998โ‚น4.45 B17.14%
1997โ‚น3.80 B-52.86%
1996โ‚น8.06 B

End of Day market cap according to different sources

On Jun 12th, 2026 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚น210.28 Billion
by Nasdaq info icon info icon
โ‚น210.28 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚น14.828 T 6,951.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.114 T 4,709.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น153.71 B-26.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น700.53 B 233.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น138.86 B-33.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น233.41 B 11.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น2.66 B-98.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น1.48 B-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น40.82 B-80.59%๐Ÿ‡บ๐Ÿ‡ธ USA